Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3390/medicina56060315 http://scihub22266oqcxt.onion/10.3390/medicina56060315 32604775!7353878!32604775     free     free     free Deprecated: Implicit conversion from float 225.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 225.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 225.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Medicina+(Kaunas) 2020 ; 56 (6): ä Nephropedia Template TP {{tp|p=32604775|t=2020. A Comprehensive Analysis of Clinical Trials in the COVID-19 Pandemic Era |pdf=|usr=}}{{32604775}} gab.com Text A Comprehensive Analysis of Clinical Trials in the COVID-19 Pandemic Era JO: Medicina (Kaunas) http://www.kidney.de/pget.php?&tw=1&pmid=32604775 #FOAvip Background and objective: Despite medical advances, we are facing the unprecedented disaster of the coronavirus disease 2019 (COVID-19) pandemic without available treatments and effective vaccines. As the COVID-19 pandemic has approached its culmination, desperate efforts have been made to seek proper treatments and response strategies, and the number of clinical trials has been rapidly increasing. In this time of the pandemic, it is believed that learning lessons from it would be meaningful in preparing for future pandemics. Thus, this study aims at providing a comprehensive landscape of COVID-19 related clinical trials based on the ClinicalTrials.gov database. Materials and methods: Up to 30 March 2020, we identified a total of 147 eligible clinical trials and reviewed the overview of the studies. Results: Until then, the most clinical trials were set up in China. Treatment approaches are the most frequent purpose of the registered studies. Chloroquine, interferon, and antiviral agents such as remdesivir, lopinavir, and ritonavir are agents under investigation in these trials. Conclusions: In this study, we introduced the promising therapeutic options that many researchers and clinicians are interested in, and to address the hidden issues behind clinical trials in this COVID-19 pandemic. Twit Text FOAVip A Comprehensive Analysis of Clinical Trials in the COVID-19 Pandemic Era ????Medicina (Kaunas) http://www.kidney.de/pget.php?&tw=1&pmid=32604775 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32604775 #FOAvip English Wikipedia <ref>{{Cite pmid|32604775}}</ref> A Comprehensive Analysis of Clinical Trials in the COVID-19 Pandemic Era #MMPMID32604775 Lee J; Shin HW; Lee JY; Kim JS; Yang JW; Lee KH; Kronbichler A; Shin JI Medicina (Kaunas) 2020[Jun]; 56 (6): ä PMID32604775show ga Background and objective: Despite medical advances, we are facing the unprecedented disaster of the coronavirus disease 2019 (COVID-19) pandemic without available treatments and effective vaccines. As the COVID-19 pandemic has approached its culmination, desperate efforts have been made to seek proper treatments and response strategies, and the number of clinical trials has been rapidly increasing. In this time of the pandemic, it is believed that learning lessons from it would be meaningful in preparing for future pandemics. Thus, this study aims at providing a comprehensive landscape of COVID-19 related clinical trials based on the ClinicalTrials.gov database. Materials and methods: Up to 30 March 2020, we identified a total of 147 eligible clinical trials and reviewed the overview of the studies. Results: Until then, the most clinical trials were set up in China. Treatment approaches are the most frequent purpose of the registered studies. Chloroquine, interferon, and antiviral agents such as remdesivir, lopinavir, and ritonavir are agents under investigation in these trials. Conclusions: In this study, we introduced the promising therapeutic options that many researchers and clinicians are interested in, and to address the hidden issues behind clinical trials in this COVID-19 pandemic. |COVID-19[MESH] |Clinical Trials as Topic/*statistics & numerical data[MESH] |Coronavirus Infections/*therapy[MESH] |Databases, Factual[MESH] |Humans[MESH] |Pandemics[MESH]A Comprehensive Analysis of Clinical Trials in the COVID-19 Pandemic E(epmc).pdf DeepDyve Pubget Overpricing